Published March 1, 2012 | Version v1
Journal article

Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer

  • 1. Harvard Radiation Oncology Program, Boston, MA (United States)
  • 2. Department of Statistics, University of Connecticut, Storrs, CT (United States)
  • 3. Prostate Cancer Foundation of Chicago, Westmont, IL (United States)
  • 4. Department of Radiation Oncology, 21 Century Oncology, Inc., Fort Myers, FL (United States)
  • 5. Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA (United States)

Description

Purpose: It has been recently shown that diabetes mellitus (DM) is significantly associated with the likelihood of presenting with high-grade prostate cancer (PCa) or Gleason score (GS) 8 to 10; however, whether this association holds for both Type 1 and 2 DM is unknown. In this study we evaluated whether DM Type 1, 2, or both are associated with high-grade PCa after adjusting for known predictors of high-grade disease. Methods and Materials: Between 1991 and 2010, a total of 15,330 men diagnosed with PCa and treated with radiation therapy were analyzed. A polychotomous logistic regression analysis was performed to evaluate whether Type 1 or 2 DM was associated with odds of GS 7 or GS 8 to 10 compared with 6 or lower PCa, adjusting for African American race, age, prostate-specific antigen (PSA) level, and digital rectal examination findings. Results: Men with Type 1 DM (adjusted odds ratio [AOR], 2.05; 95% confidence interval [CI], 1.28–3.27; p = 0.003) or Type 2 DM (AOR, 1.58; 95% CI, 1.26–1.99; p < 0.001) were significantly more likely to be diagnosed with GS 8 to 10 PCa compared with nondiabetic men. However this was not true for GS 7, for which these respective results were AOR, 1.30; 95% CI, 0.93–1.82; p = 0.12 and AOR, 1.13; 95% CI, 0.98–1.32; p = 0.10. Conclusion: Type 1 and 2 DM were associated with a higher odds of being diagnosed with Gleason score 8 to 10 but not 7 PCa. Pending validation, men who are diagnosed with Type I DM with GS 7 or lower should be considered for additional workup to rule out occult high-grade disease.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2011.07.003

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2011.07.003;
PII
S0360-3016(11)03006-9;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
82
Journal Issue
3
Journal Page Range
p. e463-e467
ISSN
0360-3016
CODEN
IOBPD3

Optional Information

Copyright
Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.